OXYGENTA PHARMACEUTICAL
Back to Income Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹40 Cr | ₹31 Cr | ₹61 Cr | ₹52 Cr | ₹14 Cr |
What is the latest Revenue of OXYGENTA PHARMACEUTICAL ?
Year | Revenue |
---|---|
Mar2024 | ₹40 Cr |
Mar2023 | ₹31 Cr |
Mar2022 | ₹61 Cr |
Mar2021 | ₹52 Cr |
Mar2020 | ₹14 Cr |
How is Revenue of OXYGENTA PHARMACEUTICAL Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹40 Cr | 27.93 | |
Mar2023 | ₹31 Cr | -48.80 | |
Mar2022 | ₹61 Cr | 16.33 | |
Mar2021 | ₹52 Cr | 279.32 | |
Mar2020 | ₹14 Cr | - |
Compare Revenue of peers of OXYGENTA PHARMACEUTICAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
OXYGENTA PHARMACEUTICAL | ₹255.2 Cr | -1.5% | -3.8% | 7.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹392,063.0 Cr | 3% | 3.5% | -15.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,749.0 Cr | 3.1% | -4.8% | 4.9% | Stock Analytics | |
CIPLA | ₹122,429.0 Cr | 1.1% | -4% | -8.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,928.0 Cr | -1.4% | -2.6% | 4.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,168.0 Cr | -0.4% | -1.1% | -7.8% | Stock Analytics |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
OXYGENTA PHARMACEUTICAL | -1.5% |
-3.8% |
7.4% |
SENSEX | 0.1% |
1.3% |
-5.1% |
You may also like the below Video Courses